Sangamo Therapeutics
SGMO
#9639
Rank
ยฃ59.46 M
Marketcap
ยฃ0.14
Share price
12.25%
Change (1 day)
-56.73%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ73.11 Million, an increase over its 2023 earnings that were of -ยฃ88.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million13.67%
2024 -ยฃ73.11 Million-17.27%
2023 -ยฃ88.36 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ96.2 Million23.17%
2019 -ยฃ78.11 Million36.33%
2018 -ยฃ57.29 Million36.89%
2017 -ยฃ41.86 Million-22.32%
2016 -ยฃ53.88 Million54.86%
2015 -ยฃ34.8 Million75.62%
2014 -ยฃ19.82 Million0.13%
2013 -ยฃ19.79 Million
2011 -ยฃ26.6 Million43.66%
2010 -ยฃ18.52 Million28.52%
2009 -ยฃ14.41 Million-23.55%
2008 -ยฃ18.85 Million2.45%
2007 -ยฃ18.4 Million19.5%
2006 -ยฃ15.4 Million50.78%
2005 -ยฃ10.21 Million75%
2004 -ยฃ5.84 Million-33.25%
2003 -ยฃ8.74 Million-62.27%
2002 -ยฃ23.17 Million102.82%
2001 -ยฃ11.43 Million23.21%
2000 -ยฃ9.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.29 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.74 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.20 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.88 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.27 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.76 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.64 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA